Stereotaxis Receives FDA Approval for MAGiC Catheter
Stereotaxis announced it obtained U.S. Food and Drug Administration approval for the MAGiC Magnetic Interventional Ablation Catheter. "FDA approval of MAGiC is a significant milestone for Stereotaxis and the community of physicians pioneering robotics in electrophysiology. It ensures the benefits of Robotic Magnetic Navigation can support patients with complex and critical heart rhythm disorders, represents a major advance in robotic cardiac ablation technology, and provides a foundation for continued technological and clinical progress. We want to thank and recognize the team members, partners, clinicians and reviewers who made this milestone possible. We look forward to seeing MAGiC serve as a key pillar in our effort to continue making robotics broadly impactful and beneficial in electrophysiologys," said David Fischel, Stereotaxis Chairman and CEO.
